SpyGlass Pharma, Inc. Share Price

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 04/03/2026 GMT			5-day change	1st Jan Change
26.68 ^USD	-0.26%		-8.41%	-

03-03	Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target	MT
03-03	Stifel Initiates SpyGlass Pharma at Buy With $42 Price Target	MT

Timeframe

Style

03-03	Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target	MT
03-03	Stifel Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03-03	Citigroup Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03-03	Leerink Initiates at Outperform With $42 Price Target	MT
03-03	Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target	MT
02-23	Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO	RE
02-11	Spyglass Pharma Insider Bought Shares Worth $5,000,000, According to a Recent SEC Filing	MT
02-09	SpyGlass Pharma Closes $172.5 Million IPO	MT
02-09	Spyglass Pharma, Inc. Appoints Habib Dable to the Board of Directors, Effective February 5, 2026	CI
02-09	SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to NASDAQ Composite Index	CI
02-06	SpyGlass Pharma Shares Rise in Nasdaq Debut	MT
02-06	SpyGlass Pharma Prices $150 Million IPO	MT
02-05	SpyGlass Pharma, Inc. has completed an IPO in the amount of $150 million.	CI

03-03	Leerink Initiates SpyGlass Pharma at Outperform With $42 Price Target	MT
03-03	Stifel Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03-03	Citigroup Initiates SpyGlass Pharma at Buy With $42 Price Target	MT
03-03	Leerink Initiates at Outperform With $42 Price Target	MT
03-03	Jefferies Initiates SpyGlass Pharma at Buy With $62 Price Target	MT

03-04	SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit	AQ
02-09	SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares	AQ
02-06	SpyGlass Pharma Announces Pricing of Initial Public Offering	AQ

Manager	Title	Age	Since
Patrick Mooney CEO	Chief Executive Officer	52	30/06/2021
Malik Kahook PSD	President	51	31/12/2018
Jean-Frédéric Viret DFI	Director of Finance/CFO	60	31/12/2025

Director	Title	Age	Since
Malik Kahook CHM	Chairman	51	31/12/2020
Ali Behbahani BRD	Director/Board Member	49	30/04/2019
Patrick Mooney BRD	Director/Board Member	52	30/06/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SPYGLASS PHARMA, INC.	-0.26%	-8.41%	-	-	889M
ESSILORLUXOTTICA	+2.29%	-7.51%	-23.16%	+33.92%	118B
ALCON INC.	+2.00%	-2.71%	-21.04%	+1.65%	40.75B
THE COOPER COMPANIES, INC.	-1.67%	-1.79%	-9.58%	-6.79%	16B
LENSKART SOLUTIONS LIMITED	-0.89%	+1.29%	-	-	9.87B
SHANGHAI CONANT OPTICAL CO., LTD.	-0.60%	-7.68%	+96.26%	+1,065.66%	3.77B
AUTEK CHINA INC.	-2.38%	-3.13%	-9.71%	-55.16%	1.97B
MINGYUE OPTICAL LENS CO.,LTD.	-1.11%	-5.43%	-31.13%	-4.60%	1.11B
MENICON CO., LTD.	+1.21%	-6.58%	+40.58%	-40.70%	821M
PEGAVISION CORPORATION	-2.97%	-5.77%	-26.20%	-36.79%	684M
Average	-0.45%	-4.44%	+2.00%	+119.65%	19.39B
Weighted average by Cap.	+1.58%	-5.26%	-18.67%	+42.64%